Item 1. Financial Statements
Item 1. Financial Statements
DARKPULSE, INC.
Consolidated Balance
Sheets
Unaudited
Audited
March 31
December 31
2025
2024
ASSETS
CURRENT ASSETS:
Cash and cash equivalents
$ 107,785
$ 86,531
Accounts receivable, net
1,051,338
915,044
Prepaid expenses and other current assets
105,697
102,782
TOTAL CURRENT ASSETS
1,264,820
1,104,357
NON-CURRENT ASSETS:
Property and equipment, net
662,052
698,982
Operating lease right-of-use assets
–
449,556
Patents, net
189,878
202,635
Notes receivable, related party
–
–
Investment in related party
–
–
Joint venture
–
–
Goodwill
23,965
23,965
Other assets, net
247,438
308,804
Intangible assets, net
–
–
TOTAL NON-CURRENT ASSETS
1,123,333
1,683,942
TOTAL ASSETS
$ 2,388,153
$ 2,788,299
LIABILITIES AND STOCKHOLDERS' DEFICIT
CURRENT LIABILITIES:
Accounts payable and accrued expenses
$ 17,331,966
$ 16,863,559
Contract liabilities
–
–
Loss provision for contracts in progress
–
–
Convertible notes, net
–
–
Notes payable, current
63,824
114,000
Derivative liability
( 57,235 )
( 57,235 )
Loan payable, current
571,458
571,530
Loan payable, related party
377,017
361,747
Secured debenture, current
274,446
260,550
Operating lease liabilities - current
–
80,400
Other current liabilities
72,197
70,513
TOTAL CURRENT LIABILITIES
18,633,673
18,265,063
NON-CURRENT LIABILITIES:
Secured debenture
685,998
781,094
Loan payable
291,967
291,967
Operating lease liabilities - non-current
–
447,009
Non-current liabilities - discontinued operations
–
–
TOTAL NON-CURRENT LIABILITIES
977,965
1,520,070
TOTAL LIABILITIES
19,611,638
19,785,133
Commitments and contingencies
–
–
STOCKHOLDERS' DEFICIT:
Series A Super Voting preferred stock - par value $ 0.01 ; 100
shares designated, 100
shares issued and outstanding at both March 31, 2025, 2024 and December 31, 2024
1
1
Convertible preferred stock - Series D, par value $ 0.01 , 100,000
shares designated, 88,235
shares issued and outstanding as of both March 31, 2025 and December 31, 2024
883
883
Common stock, par value $ 0.0001 , 20,000,000,000
shares authorized, 12,186,976,200
and 10,551,957,534
shares issued as of March 31, 2025 and December 31, 2024, respectively,
1,200,143
1,055,196
Treasury stock at cost, 100,000
shares at March 31, 2025 and December 31, 2024
( 1,000 )
( 1,000 )
Additional paid-in capital
51,470,665
51,157,797
Common Stock to be issued
2,451,601
2,470,046
Non-controlling interests
1,203,452
1,207,006
Accumulated other comprehensive income (loss)
( 2,022,761 )
( 1,627,086 )
Accumulated deficit
( 71,526,469 )
( 71,259,677 )
TOTAL STOCKHOLDERS' DEFICIT
( 17,223,485 )
( 16,996,834 )
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT
$ 2,388,153
$ 2,788,299
See
the accompanying notes to the unaudited condensed consolidated financial statements
3
DARKPULSE, INC.
CONDENSED CONSOLIDATED
STATEMENT OF OPERATIONS
UNAUDITED
Three Months Ended
March 31,
2025
2024
REVENUES
$ 141,018
$ 10,850
COST OF REVENUES
103,917
199
GROSS PROFIT (LOSS)
37,101
10,651
26%
98%
OPERATING EXPENSES:
Selling, general and administrative
144,825
157,111
Salaries, wages and payroll taxes
237,005
211,877
Professional fees
47,273
157,371
Depreciation and amortization
30,011
19,288
Bad debt expense
–
–
Impairment expense
–
–
Gain on forgiveness of payables
–
–
TOTAL OPERATING EXPENSES
459,114
545,646
OPERATING LOSS
( 422,013 )
( 534,995 )
OTHER INCOME (EXPENSE):
Interest expense
( 8,001 )
( 1,402 )
Loss on deconsolidation
–
–
Change in fair market of derivative liabilities
–
–
Loss on equity investment
–
–
Gain on the forgiveness of debt
181,055
–
Exceptional Costs gain
( 18,772 )
–
Foreign currency exchange rate variance
( 2,613 )
–
TOTAL OTHER INCOME (EXPENSE)
151,669
( 1,402 )
–
Net loss from continuing operations
( 270,344 )
( 536,398 )
Loss from discontinued operations, net of tax
–
–
Net income (loss)
( 270,344 )
( 536,398 )
Net loss attributable to non-controlling interests
3,554
3,009
Net loss attributable to Darkpulse, Inc.
$ ( 266,790 )
$ ( 533,389 )
Net loss per share - basic and diluted
$ ( 0.00 )
$ ( 0.00 )
Weighted average common shares outstanding - basic and diluted
11,309,820,561
7,411,100,872
Three Months Ended
March 31,
2025
2024
NET LOSS
$ ( 270,344 )
$ ( 536,398 )
OTHER COMPREHENSIVE INCOME (LOSS)
Foreign currency translation
( 395,675 )
1
COMPREHENSIVE LOSS
$ ( 666,018 )
$ ( 536,397 )
See
the accompanying notes to the unaudited condensed consolidated financial statements
4
DARKPULSE, INC.
Consolidated Statement
of Stockholders' Deficit
For the Three Months
Ended March 31, 2025 and 2024
Unaudited
Preferred Stock
Series
A
Series
D
Common
stock
Common
stock to be issued
Shares
Amount
Shares
Amount
Shares
Amount
Shares
Amount
Balance at December 31, 2023
100
1
88,235
883
8,100,117,720
798,346
–
205,000
Common stock issued for cash, net of fees
–
–
–
–
52,162,997
5,218
–
–
Issuance of common stock for legal settlement
–
–
–
–
–
–
–
–
Common Stock to be issued
–
–
–
–
–
–
–
–
Foreign currency adjustment
–
–
–
–
–
–
–
–
Net loss
–
–
–
–
–
–
–
–
Balance at March 31, 2024
100
$ 1
88,235
$ 883
8,152,280,717
$ 803,564
–
$ 205,000
Preferred
Stock
Series A
Series D
Common stock
Common stock to be issued
Shares
Amount
Shares
Amount
Shares
Amount
Shares
Amount
Balance at December 31, 2024
100
$ 1
88,235
$ 883
10,551,957,534
$ 1,055,196.00
2,545,555,556
$ 2,470,046
Common stock issued for cash, net of fees
–
–
–
–
1,265,018,666
126,502
–
–
Conversion of convertible debt into common stock
–
–
–
–
–
–
–
–
Issuance of common stock for legal settlement
–
–
–
–
250,000,000
–
( 250,000,000 )
–
Common Stock to be issued
–
–
–
–
120,000,000
18,445
( 120,000,000 )
( 18,445 )
Foreign currency adjustment
–
–
–
–
–
–
–
–
Net Income (loss)
–
–
–
–
–
–
–
–
Balance at March 31, 2025
100
$ 1
88,235
$ 883
12,186,976,200
$ 1,200,143
2,175,555,556
$ 2,451,601
See
the accompanying notes to the unaudited condensed consolidated financial statements
5
DARKPULSE, INC.
Consolidated Statement
of Stockholders' Deficit
For the Three Months
Ended March 31, 2025 and 2024
Unaudited
Treasury stock
Additional paid-in
Non- controlling
Accumulated other comprehensive
Accumulated
Total
stockholders’ deficit
Shares
Amount
capital
interests
loss
deficit
(equity)
Balance at December 31, 2023
100,000
( 1,000 )
49,733,618
1,217,410
( 1,253,356 )
( 67,376,221 )
( 16,675,319 )
Common stock issued for cash, net of fees
–
–
35,364
–
–
–
40,582
Issuance of common stock for legal settlement
–
–
100,000
–
–
–
100,000
Common Stock to be issued
–
–
–
–
–
–
–
Foreign currency adjustment
–
–
–
–
–
–
–
Common stock issued for cash
–
–
–
–
–
–
–
Net loss
–
–
–
( 3,009 )
–
( 533,389 )
( 536,398 )
Balance at March 31, 2024
100,000
$ ( 1,000 )
$ 49,868,982
$ 1,214,401
$ ( 1,253,356 )
$ ( 67,909,611 )
$ ( 17,071,135 )
Treasury stock
Additional paid-in
Non- controlling
Accumulated other comprehensive
Accumulated
Total
stockholders’ deficit
Shares
Amount
capital
interests
loss
deficit
(equity)
Balance at December 31, 2024
100,000
$ ( 1,000.00 )
$ 51,157,797
$ 1,207,006
$ ( 1,627,086 )
$ ( 71,259,677 )
$ ( 16,996,834 )
Common stock issued for cash, net of fees
–
–
312,868
–
–
–
439,370
Conversion of convertible debt into common stock
–
–
–
–
–
–
–
Issuance of common stock for legal settlement
–
–
–
–
–
–
–
Common Stock to be issued
–
–
–
–
–
–
–
Foreign currency adjustment
–
–
–
–
( 395,675 )
–
( 395,675 )
Net Income (loss)
–
–
–
( 3,554 )
–
( 266,790 )
( 270,344 )
Balance at March 31, 2025
100,000
$ ( 1,000 )
$ 51,470,665
$ 1,203,452
$ ( 2,022,761 )
$ ( 71,526,469 )
$ ( 17,223,485 )
See
the accompanying notes to the unaudited condensed consolidated financial statements
6
DARKPULSE, INC.
CONSOLIDATED STATEMENT OF CASH FLOWS
UNAUDITED
Three Months Ended
March 31,
2025
2024
Cash flows from operating activities:
Net loss
$ ( 270,344 )
$ ( 536,398 )
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
30,011
19,288
Gain on forgiveness of payables and liabilities
181,055
–
Change in fair market of derivative liabilities
–
–
Impairment of goodwill and intangible assets
–
–
Loss on equity investment
–
–
Issuance of common stock for legal settlement
–
–
Amortization of debt discount
–
–
Bad debt expense
–
–
Exceptional Costs gain
25,260
–
Operating lease expense
–
11,507
Changes in operating assets and liabilities:
Accounts receivable
( 136,294 )
( 12,918 )
Inventory
–
–
Contract assets
–
–
Prepaid expenses and other assets
58,451
989
Contract liabilities
–
–
Loss provision for contracts in progress
–
–
Accounts payable and accrued expenses
266,803
437,569
Operating lease liabilities, net
( 527,409 )
( 11,790 )
Other current liabilities
1,684
66
Other assets
449,556
–
Other liabilities
–
–
Net cash provided (used) in operating activities
78,774
( 91,687 )
Cash flows from investing activities:
Purchases of property and equipment
19,675
–
Investment in joint venture
–
–
Issuance of note receivable, related party
–
( 29,817 )
Advances to related party
–
( 30,000 )
Net cash provided (used) in investing activities
19,675
( 59,817 )
Cash flows from financing activities:
Issuance of common stock, net of fees
439,370
140,580
Proceeds from convertible notes
15,270
–
Net repayments of loan payable
( 136,159 )
–
Net cash provided (used) by financing activities
318,481
140,580
Net change in cash
416,929
( 10,923 )
Effect of exchange rate on cash
( 395,675 )
–
Cash at beginning of year
86,531
11,912
Cash at end of year
$ 107,785
$ 990
Supplemental disclosure of cash flow information:
Cash paid for interest
$ –
$ –
Cash paid for income taxes
$ –
$ –
Non-cash financing and investing activities:
Conversion of convertible debt
$ –
$ –
See
the accompanying notes to the unaudited condensed consolidated financial statements
7
DARKPULSE, INC.
NOTES
TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
UNAUDITED
NOTE 1 – BASIS OF FINANCIAL STATEMENT PRESENTATION
Organization and Description of Business
DarkPulse, Inc. (“DPI” or “Company”)
is a technology-security company incorporated in 1989 as Klever Marketing, Inc. (“Klever”). Its’ wholly- owned subsidiary,
DarkPulse Technologies Inc. (“DPTI”), originally started as a technology spinout from the University of New Brunswick, Fredericton,
Canada. The Company’s security and monitoring systems will initially be delivered in applications for border security, pipelines,
the oil and gas industry and mine safety. Current uses of fiber optic distributed sensor technology have been limited to quasi-static,
long-term structural health monitoring due to the time required to obtain the data and its poor precision. The Company’s patented
BOTDA dark-pulse sensor technology allows for the monitoring of highly dynamic environments due to its greater resolution and accuracy.
The Company’s subsidiaries consist of: DarkPulse,
Inc., based in New York; Terradata Unmanned PLLC, based in Florida; DarkPulse UK Ltd based in the United Kingdom, Optilan India Pvt Ltd
based in Navi-Mumbai and Optilan Communications & Security Systems Ltd, based in Ankara Turkey.
Optilan India Pvt Ltd, operating in India, provides
project engineering & design, system provisioning and contract bid services for the Company globally. Optilan Communications &
Security Systems Ltd, provides project engineering & design, system provisioning and contract bid services for the Company throughout
Europe.
DarkPulse Manufacturing Inc., based in Arizona
(formerly TJM Electronics West, Inc.), is no longer providing products or services as a result of the Company’s relationship with
Sanmina Corporation who is handling both the design and manufacturing of the Company’s patented hardware.
Remote Intelligence, LLC and Wildlife Specialists,
LLC are no longer providing services as a result of redundant service offerings that are now being offered by TerraData Unmanned.
NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES
A summary of the significant accounting policies
consistently applied in the preparation of the accompanying financial statements are as follows:
Basis of Presentation and Principles of Consolidation
The Company’s consolidated financial statements
are prepared in accordance with accounting principles generally accepted in the United States (“US GAAP”). The consolidated
financial statements of the Company include the Company and its wholly-owned subsidiaries. All material intercompany balances and transactions
have been eliminated in consolidation.
The Company evaluates its relationships with other
entities to identify whether they are variable interest entities (“VIE”) as defined by Financial Accounting Standards Board
(“FASB”) Accounting Standards Codification (“ASC”) Topic 810, Consolidation (“ASC 810”), and
to assess whether it is the primary beneficiary of such entities. If the determination is made that the Company is the primary beneficiary,
then that entity is consolidated.
8
Use of Estimates
The preparation of the Company’s financial
statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and
liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of
revenues and expenses during the reporting period. Significant estimates and assumptions reflected in these financial statements include,
but are not limited to, assumptions used to calculate derivative liabilities, revenue recognition and impairment of long-lived assets.
The Company bases its estimates on historical experience, known trends and other market-specific or other relevant factors that it believes
to be reasonable under the circumstances. On an ongoing basis, management evaluates its estimates when there are changes in circumstances,
facts and experience. Changes in estimates are recorded in the period in which they become known. Actual results could differ from those
estimates.
Cash
The Company considers all highly liquid investments
with a maturity of three months or less when acquired to be cash equivalents. The Company places its cash with high credit quality financial
institutions. The Company’s account at this institution is insured by the Federal Deposit Insurance Corporation (“FDIC”)
up to $250,000. To reduce its risk associated with the failure of such a financial institution, the Company evaluates at least annually
the rating of the financial institution in which it holds deposits.
Accounts Receivable
Accounts receivable and contract assets include
amounts billed to customers under the terms and provisions of the contracts. Most billings are determined based on contractual terms.
As is common practice in the industry, the Company classifies all accounts receivable and contract assets, including retainage, as current
assets. The contracting cycle for certain long-term contracts may extend beyond one year, and accordingly, collection of retainage on
those contracts may extend beyond one year. Contract assets include amounts billed to customers under retention provisions in construction
contracts. Such provisions are standard in the Company’s industry and usually allow for a portion of progress billings on the contract
price, typically 5-10%, to be withheld by the customer until after the Company has completed work on the project. Billings for such retention
balances at each balance sheet date are finalized and collected after project completion. Generally, unbilled amounts will be billed and
collected within one year. The Company determined that there are no material amounts due past one year and no material amounts billed
but not expected to be collected within one year. Also, the Company adopted ASU 2016-13 in January 2023 and the adoption did not have
a material impact on the Company’s consolidated financial statements and related disclosures for the year ended December 31, 2024.
Each month, the Company reviews its receivables
on a customer-by-customer basis and evaluates whether an allowance for doubtful accounts is necessary based on any known or perceived
collection issues. Any balances that are eventually deemed uncollectible are written off against the allowance after all means of collection
have been exhausted and the potential for recovery is considered remote. As of December 31, 2024 and 2023, the Company determined that
the allowance for doubtful accounts was $ 5,457
and $ 0 , respectively.
The allowance pertaining to Optilan UK was derecognized upon the Optilan Liquidation.
Foreign Currency Translation
The Company’s reporting currency is US Dollars.
The accounts of one of the Company’s subsidiaries is maintained using the appropriate local currency, British Pound (“GBP”)
as the functional currency, as well as the Turkish lira, Emiraes Dirham, Azerbajani Manat and Indian Rupee. The accounts of one of the
Company’s subsidiaries is maintained using the appropriate local currency, Canadian Dollar (“CAD”) as the functional
currency. All assets and liabilities are translated into U.S. Dollars at balance sheet date, shareholders' equity is translated at historical
rates and revenue and expense accounts are translated at the average exchange rate for the year or the reporting period. The translation
adjustments are reported as a separate component of stockholders’ equity, captioned as accumulated other comprehensive (loss) gain.
Transaction gains and losses arising from exchange rate fluctuations on transactions denominated in a currency other than the functional
currency are included in the statements of operations as foreign currency exchange variance.
The relevant translation rates are as follows:
for the year ended March 31, 2025 a closing rate at 1.292 US$: GBP, average rate at 1.2633 US$:GBP, and closing rate of 1.4391 US$:CAD.
The relevant translation rates are as follows:
for the year ended March 31, 2024 a closing rate at 1.2626
US$: GBP, average rate at 1.2713
US$:GBP and closing rate at 1.3510
US$: CAD.
9
Long-Lived Assets and Goodwill
The Company accounts for long-lived assets in
accordance with the provisions of ASC 360-10-35, Property, Plant and Equipment, Impairment or Disposal of Long-lived Assets. This
accounting standard requires that long-lived assets be reviewed for impairment whenever events or changes in circumstances indicate that
the carrying amount may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount
of an asset to future undiscounted net cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its
estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair
value of the asset.
Indefinite-lived intangible assets established
in connection with business combinations consist of the tradename. The impairment test for identifiable indefinite-lived intangible assets
consists of a comparison of the estimated fair value of the intangible asset with its carrying value. If the carrying value exceeds its
fair value, an impairment loss is recognized in an amount equal to that excess.
The Company accounts for goodwill and intangible
assets in accordance with ASC 350, Intangibles – Goodwill and Other . Goodwill represents the excess of the purchase price
of an entity over the estimated fair value of the assets acquired and liabilities assumed. ASC 350 requires that goodwill and other intangibles
with indefinite lives be tested for impairment annually or on an interim basis if events or circumstances indicate that the fair value
of an asset has decreased below its carrying value. This guidance simplifies the accounting for goodwill impairment by removing Step
2 of the goodwill impairment test, which requires a hypothetical purchase price allocation. The quantitative impairment test calculates
any goodwill impairment as the difference between the carrying amount of a reporting unit and its fair value, but not to exceed the carrying
amount of goodwill. It is our practice, at a minimum, to perform a qualitative or quantitative goodwill impairment test in the fourth
quarter every year. The Company has one reporting unit it evaluates during its impairment test.
Property and Equipment
Property and equipment are carried at historical
cost less accumulated depreciation. Depreciation is based on the estimated service lives of the depreciable assets and is calculated
using the straight-line method. Expenditures that increase the value or productive capacity of assets are capitalized. Fully depreciated
assets are retained in the property and equipment, and accumulated depreciation accounts until they are removed from service. When property
and equipment are retired, sold or otherwise disposed of, the asset’s carrying amount and related accumulated depreciation are
removed from the accounts and any gain or loss is included in operations. Repairs and maintenance are expensed as incurred.
The estimated useful lives of property and equipment
are generally as follows:
Schedule of estimated useful lives of property and equipment
Years
Office furniture and fixtures
4
Plant and equipment
4-8
Leasehold Improvements
10
Motor vehicles
3
Revenue Recognition
The Company’s revenues are generated primarily
from the sale of our services, which consist primarily of advanced technology solutions for integrated communications and security systems,
as well as habitat management. The Company’s sales of products are primarily generated from our TJM subsidiaries. Sales of products
and services are separate from one another. At contract inception, we assess the goods and services promised in the contract with customers
and identify a performance obligation for each. To determine the performance obligation, we consider all products and services promised
in the contract regardless of whether they are explicitly stated or implied by customary business practices. The timing of satisfaction
of the performance obligation is not subject to significant judgment. We measure revenue as the amount of consideration expected to be
received in exchange for transferring goods and services. We recognize service revenues as the performance obligations are met, which
is generally as milestones are satisfied over time. We generally recognize product revenues at the time of shipment, provided that all
other revenue recognition criteria have been met.
10
The Company recognizes revenue when its customer
obtains control of promised goods or services, in an amount that reflects the consideration which we expect to receive in exchange for
those goods or services. To determine revenue recognition for arrangements that the Company determines are within the scope of ASC 606,
we perform the following five steps: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract;
(iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize
revenue when (or as) we satisfy a performance obligation. The five-step model is applied to contracts when it is probable that we will
collect the consideration we are entitled to in exchange for the goods or services transferred to the customer. At contract inception,
once the contract is determined to be within the scope of ASC 606, we assess the goods or services promised within each contract and determine
those that are performance obligations and assess whether each promised good or service is distinct. We then recognize revenue in the
amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is
satisfied.
The Company considers each individual sale of
service contract to be its own performance obligation. Services in the contract are highly interdependent and interrelated, and the successful
completion of each milestone is necessary for the overall success of the contract. Therefore, each milestone is not separately identifiable
from other promises in the contract, and not distinct and ultimately not individual performance obligations.
The Company records revenue over time using the
input measure as it is the most faithful depiction of an entity’s performance because it directly measures the value of the goods
and services transferred to the customer. The Company utilizes the Right to Invoice for these contracts, as the pricing structure is
based on various milestones that are specified in the contract. These milestones include Construction Phase Plan, Start of the construction
phase, installation phase, site surveys, fiber splicing, recoveries, and closeouts. There are specified payments associated with these
milestones in the contract, and the value allocated is commensurate with work done. In the event that there are advances such as upfront
retainers and not based on the value, those are recorded as contract liabilities.
In accordance with ASU No. 2016-12, Revenue
from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedient , which is to (1) clarify the objective
of the collectability criterion for applying paragraph 606-10-25-7; (2) permit an entity to exclude amounts collected from customers
for all sales (and other similar) taxes from the transaction price; (3) specify that the measurement date for noncash consideration is
contract inception; (4) provide a practical expedient that permits an entity to reflect the aggregate effect of all modifications that
occur before the beginning of the earliest period presented when identifying the satisfied and unsatisfied performance obligations, determining
the transaction price, and allocating the transaction price to the satisfied and unsatisfied performance obligations; (5) clarify that
a completed contract for purposes of transition is a contract for which all (or substantially all) of the revenue was recognized under
legacy GAAP before the date of initial application, and (6) clarify that an entity that retrospectively applies the guidance in Topic
606 to each prior reporting period is not required to disclose the effect of the accounting change for the period of adoption. The amendments
of this ASU are effective for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. There was
no impact as a result of adopting this ASU on the financial statements and related disclosures. Based on the terms and conditions of
the product arrangements, the Company believes that its products and services can be accounted for separately as its products and services
have value to the Company’s customers on a stand-alone basis. When a transaction involves more than one product or service, revenue
is allocated to each deliverable based on its relative fair value; otherwise, revenue is recognized as products are delivered or as services
are provided over the term of the customer contract.
Cost of Revenues
Cost of revenues consists primarily of materials
and overhead costs incurred internally and amounts incurred to contract manufacturers to produce our products, airtime and other implementation
costs incurred to install our products and train customer personnel, and customer service and third- party original equipment manufacturer
costs to provide continuing support to our customers. Cost of revenues also includes direct labor attributable to revenue service arrangements.
11
Concentration of Credit Risk
Financial instruments that potentially
subject the Company to concentrations of credit risk consist principally of cash and cash equivalents. The Company has not
experienced any losses related to its cash and does not believe that it is subject to unusual credit risk beyond the normal credit
risk associated with commercial banking relationships. As of March 31, 2025, one customer accounted for 39 %
of gross accounts receivable.
Leases
The Company accounts for its leases under ASC
842, Leases . Under this guidance, arrangements meeting the definition of a lease are classified as operating or financing leases
and are recorded on the consolidated balance sheet as both a right of use asset and lease liability, calculated by discounting fixed lease
payments over the lease term at the rate implicit in the lease or the Company’s incremental borrowing rate. Lease liabilities are
increased by interest and reduced by payments each period, and the right of use asset is amortized over the lease term. For operating
leases, interest on the lease liability and the amortization of the right of use asset result in straight-line rent expense over the lease
term. For finance leases, interest on the lease liability and the amortization of the right of use asset results in front-loaded expense
over the lease term. Variable lease expenses are recorded when incurred.
In calculating the right of use asset and lease
liability, the Company has elected to combine lease and non-lease components. The Company excludes short-term leases having initial terms
of 12 months or less from the new guidance as an accounting policy election and recognizes rent expense on a straight-line basis over
the lease term.
Derivative Financial Instruments
The Company evaluates the embedded conversion
feature within its convertible debt instruments under ASC 815-15 and ASC 815-40 to determine if the conversion feature meets the definition
of a liability and, if so, whether to bifurcate the conversion feature and account for it as a separate derivative liability. For derivative
financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is
then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivative
financial instruments, the Company uses a lattice model, in accordance with ASC 815-15 , Derivative and Hedging, to value the derivative
instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments
should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are
classified in the balance sheet as current or non-current based on whether net-cash settlement of the derivative instrument could be
required within 12 months after the balance sheet date.
Fair Value of Financial Instruments
The Company measures its financial assets and
liabilities in accordance with the requirements of FASB ASC 820, Fair Value Measurements and Disclosures. As defined in FASB ASC
820, the fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between
market participants at the measurement date (exit price). The Company utilized the market data of similar entities in its industry or
assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent
in the inputs to the valuation technique. These inputs can be readily observable, market corroborated, or generally unobservable. The
Company classifies fair value balances based on the observability of those inputs. FASB ASC 820 established a fair value hierarchy that
prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets
for identical assets or liabilities (level 1 measurement) and the lowest priority to unobservable inputs (level 3 measurement) as follows:
Level 1 – Quoted prices are available in
active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset
or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. Level 1 primarily consists of
financial instruments such as exchange-traded derivatives, marketable securities and listed equities.
12
Level 2 – Pricing inputs are other than
quoted prices in active markets included in level 1, which are either directly or indirectly observable as of the reported date and includes
those financial instruments that are valued using models or other valuation methodologies. These models are primarily industry-standard
models that consider various assumptions, including quoted forward prices for commodities, time value, volatility factors, and current
market and contractual prices for the underlying instruments, as well as other relevant economic measures. Substantially all of these
assumptions are observable in the marketplace throughout the full term of the instrument, can be derived from observable data or are supported
by observable levels at which transactions are executed in the marketplace. Instruments in this category generally include non- exchange-traded
derivatives such as commodity swaps, interest rate swaps, options and collars.
Level 3 – Pricing inputs include significant
inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that
result in management’s best estimate of fair value.
The Company’s derivative liability is a
Level 3 liability measured at fair value on a recurring basis. See Note 10.
Equity Investments
The Company uses the equity method to account
for investments in which it has the ability to exercise significant influence over the investee’s operating and financial policies,
or in which its holds a partnership or limited liability company interest in an entity with specific ownership accounts, unless it has
virtually no influence over the investee’s operating and financial policies. The Company follows the guidance in ASC 323-10-30-2,
Joint Ventures, which prescribes the use of the equity method for investments in joint ventures where the Company has significant influence.
Equity method investments are recorded at cost and are adjusted to recognize (1) the Company’s share, based on percentage ownership
or other contractual basis, of the investee’s net income or loss after the date of investment, (2) amortization of the recorded
investment that exceeds the Company’s share of the book value of the investee’s net assets, (3) additional contributions made
and dividends received, and (4) impairments resulting from other-than-temporary declines in fair value. Gain (loss) on equity investment
includes realized gains or losses upon the sale of the investment and are included as other income (expense) in the consolidated statements
of operations and comprehensive (loss).
Per ASC 323-10-30-2, Joint Ventures are accounted
for using the equity method, in which the Company initially records its investment at cost, including transaction costs. Under the equity
method, an investment in common stock and in-substance common stock is presented on the balance sheet of an investor as a single amount.
However, any difference between the cost of the investment and the underlying equity in net assets of an investee — commonly referred
to as a basis difference — should be accounted for as if the investee were a consolidated subsidiary.
Income Taxes
The Company accounts for income taxes pursuant
to the provision of ASC 740-10, (“ASC 740-10”) which requires, among other things, an asset and liability approach to calculating
deferred income taxes. The asset and liability approach requires the recognition of deferred tax assets and liabilities for the expected
future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities. A valuation
allowance is provided to offset any net deferred tax assets for which management believes it is more likely than not that the net deferred
asset will not be realized.
The Company follows the provision of ASC 740-10
related to Accounting for Uncertain Income Tax Positions. When tax returns are filed, there may be uncertainty about the merits of positions
taken or the amount of the position that would be ultimately sustained. In accordance with the guidance of ASC 740-10, the benefit of
a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes
it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes,
if any. Tax positions taken are not offset or aggregated with other positions.
13
Tax positions that meet the more likely than not
recognition threshold are measured at the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement
with the applicable taxing authority. The portion of the benefit associated with tax positions taken that exceed the amount measured as
described above should be reflected as a liability for uncertain tax benefits in the accompanying balance sheet along with any associated
interest and penalties that would be payable to the taxing authorities upon examination.
The Company believes its tax positions are all
more likely than not to be upheld upon examination. As such, the Company has not recorded a liability for uncertain tax benefits.
The Company has adopted ASC 740-10-25, Definition
of Settlement which provides guidance on how an entity should determine whether a tax position is effectively settled for the purpose
of recognizing previously unrecognized tax benefits and provides that a tax position can be effectively settled upon the completion and
examination by a taxing authority without being legally extinguished. For tax positions considered effectively settled, an entity would
recognize the full amount of tax benefit, even if the tax position is not considered more likely than not to be sustained based solely
on the basis of its technical merits and the statute of limitations remains open. The federal and state income tax returns of the Company
are subject to examination by the IRS and state taxing authorities, generally for three years after they are filed.
The Company's U.S. subsidiaries were incorporated
in 2017. The Company does not anticipate a tax liability for the years 2024 and 2023, however may be subject to certain penalties. The
Company has filed tax returns in Canada for the year ended December 31, 2018, and they are still subject to audit.
Non-controlling Interests
Non-controlling interests are classified as a
separate component of equity in the Company's consolidated balance sheets and statements of changes in stockholders’ equity. Net
income (loss) and comprehensive income (loss) attributable to non-controlling interests are reflected separately from consolidated net
income (loss) and comprehensive income (loss) in the consolidated statements of comprehensive income (loss) and statements of changes
in stockholders’ equity. Any change in ownership of a subsidiary while the controlling financial interest is retained is accounted
for as an equity transaction between the controlling and non-controlling interests. In addition, when a subsidiary is deconsolidated,
any retained non- controlling equity investment in the former subsidiary will be initially measured at fair value and the difference between
the carrying value and fair value of the retained interest will be recorded as a gain or loss. The Company has non-controlling interests
via its subsidiaries TerraData, Remote Intelligence and Wildlife Specialists.
During the three months ended March 31, 2025
and 2024, the Company recorded a loss of $ 3,554
and $ 3,009
respectively, attributable to non- controlling interests.
Comprehensive Loss
Comprehensive loss includes net loss well as other
changes in stockholders’ equity that result from transactions and economic events other than those with stockholders. During the
three months ended March 31, 2025 and 2024, the Company’s only element of other comprehensive loss was foreign currency translation.
Stock-based Compensation
Stock-based compensation is accounted for based
on the requirements of the Share-Based Payment Topic of ASC 718 which requires recognition in the consolidated financial statements of
the cost of employee and director services received in exchange for an award of equity instruments over the period the employee or director
is required to perform the services in exchange for the award (presumptively, the vesting period). The ASC also requires measurement of
the cost of employee and director services received in exchange for an award based on the grant-date fair value of the award.
14
Pursuant to ASC Topic 718, for share-based payments
to consultants and other third-parties, compensation expense is determined at the “measurement date.” The expense is recognized
over the vesting period of the award. Until the measurement date is reached, the total amount of compensation expense remains uncertain.
The Company initially records compensation expense based on the fair value of the award at the reporting date. Further, ASC Topic 718,
provides guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification
accounting in Topic 718, such as the repricing of share options, which would revalue those options and the accounting for the cancellation
of an equity award whether a replacement award or other valuable consideration is issued in conjunction with the cancellation. If not,
the cancellation is viewed as a replacement and not a modification, with a repurchase price of $ 0 .
Loss Per Common Share
The Company accounts for earnings per share pursuant
to ASC 260, Earnings per Share , which requires disclosure on the financial statements of "basic" and "diluted"
earnings (loss) per share. Basic earnings (loss) per share are computed by dividing net income (loss) by the weighted average number
of common shares outstanding for the year. Diluted earnings (loss) per share is computed by dividing net income (loss) by the weighted
average number of common shares outstanding plus common stock equivalents (if dilutive) related to stock options and warrants for each
year. In periods where the Company has a net loss, all dilutive securities are excluded. Potentially dilutive items outstanding as of
December March 31, 2025 and 2024 are as follows:
Schedule of anti dilutive securities
Years Ended
2025
2024
Convertible notes
–
210,081,967
Series D preferred stock
176,470
176,470
176,470
210,258,470
Recently Issued Accounting Pronouncements
On January 1, 2023, the Company adopted ASU 2016-13,
Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (ASC 326). This
standard replaced the incurred loss methodology with an expected loss methodology that is referred to as the current expected credit loss
(“CECL”) methodology. CECL requires an estimate of credit losses for the remaining estimated life of the financial asset using
historical experience, current conditions, and reasonable and supportable forecasts and generally applies to financial assets measured
at amortized cost, including loan receivables and held-to-maturity debt securities, and some off-balance sheet credit exposures such as
unfunded commitments to extend credit. Financial assets measured at amortized cost will be presented at the net amount expected to be
collected by using an allowance for credit losses. The Company adopted this new guidance on January 1, 2023 and the adoption did not have
a material impact on the Company’s consolidated financial statements and related disclosures.
Management does not believe that any other recently
issued, but not yet effective, accounting standards could have a material effect on the accompanying financial statements. As new accounting
pronouncements are issued, the Company will adopt those that are applicable.
15
NOTE 3 – LIQUIDITY AND GOING CONCERN
The Company generated net losses of $ 270,344
and $ 536,398 during the three months ended
March 31, 2025 and 2024, respectively, and net cash provided (used) in operating activities of $ 78,774
and $ ( 91,687 ) ,
respectively. As of March 31, 2025, the Company’s current liabilities exceeded its current assets by $ 17,368,854
and an accumulated deficit of $ 71,526,469 . As of March 31, 2025, the Company had $ 107,785 of cash.
The Company will require additional funding during
the next twelve months to finance the growth of its current operations and achieve its strategic objectives. These factors, as well as
the uncertain conditions that the Company faces relative to capital raising activities, create substantial doubt as to the Company’s
ability to continue as a going concern. The Company is seeking to raise additional capital principally through private placement offerings
and is targeting strategic partners in an effort to finalize the development of its products and begin generating revenues. The ability
of the Company to continue as a going concern is dependent upon the success of future capital offerings or alternative financing arrangements
or expansion of its operations. The accompanying consolidated financial statements do not include any adjustments that might be necessary
should the Company be unable to continue as a going concern. Management is actively pursuing additional sources of financing sufficient
to generate enough cash flow to fund its operations for twelve months from the issuance date of these consolidated financial statements.
However, management cannot make any assurances that such financing will be secured.
NOTE 4 – BUSINESS ACQUISITIONS
Optilan India PVT Ltd and Optilan Communication
& Security Systems, Ltd.
On September 11, 2024, the Company closed a sale agreement with Joint
Liquidators, Optilan (UK) Limited incorporated and registered in England and Wales acting by the Joint Liquidators (Seller), purchasing
the right, title and interest of shares in Optilan India, PVT Ltd located in Kilpauk, Chennai India and Optilan Communication & Security
Systems, Ltd located in Ankara, Turkey along with the applicable intellectual property rights including (1) the user interface for sensor
systems, (2) The “Optilan.com” domain
name and continued use of the “@optilan.com” email accounts. The Company agreed to pay $ 65,000 USD for both companies and
the intellectual property rights.
The Company has accounted for the purchase using
the acquisition method of accounting for business combinations under ASC 805. Accordingly, the purchase price has been allocated to the
underlying assets and liabilities in proportion to their respective actual values as of the purchase date. The excess of the consideration
transferred over the actual estimated fair values of the net assets acquired was recorded as goodwill. The following table summarizes
the acquired assets and assumed liabilities for the actual value of the assets and liabilities recognized at the date of acquisition:
Schedule of acquired assets and assumed
liabilities
Consideration
Property, Plant & Equipment
$ 22,100
Shares
42,900
Purchase price
$ 65,000
16
The allocation of the total purchase price to
the tangible and intangible assets acquired and liabilities assumed by DarkPulse based on actual values as of September 11, 2024, and
measurement period adjustments resulting from the Optilan India fiscal audit period April 2023 – March 2024 which was completed
in December 2024 are as follows:
Schedule of fair value assets acquired and liabilities
(Amounts in US$’s)
Amounts Recognized as of Acquisition Date
Measurement
Period
Adjustments
Fair Value
Cash
$ 1,637
$ 199
$ 1,836
Accounts receivable
128,392
61,376
189,732
Other current assets
89,082
56,455
145,536
Property & equipment
35,595
( 2,246 )
33,349
Goodwill
181,478
( 156,563 )
24,770
Total assets
436,184
( 40,779 )
395,223
Assumed liabilities
371,184
56,755
314,247
Gain on acquisition
–
( 15,976 )
( 15,976 )
Total Consideration for 100% of equity interests
$ 65,000
$ –
$ 65,000
NOTE 5 – REVENUE
The following table is a summary of the Company’s
timing of revenue recognition for the three months ended March 31, 2025 and 2024:
Schedule of timing of revenue
recognition
Three Months Ended
March 31,
2025
2024
Services and products transferred at a point in time
$ 141,018
$ 4,232
Services and products transferred over time
–
6,619
Total revenue
$ 141,018
$ 10,850
The Company disaggregates revenue by source and
geographic destination to depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors.
Revenue by source consisted of the following for
the three months ended March 31, 2025 and 2024:
Schedule of revenue by source
Three Months Ended
March 31,
2025
2024
Products
$ –
$ –
Services
141,018
10,850
Total revenue
$ 141,018
$ 10,850
Revenue by geographic destination consisted of
the following for the three months ended March 31, 2025 and 2024:
Schedule of revenue by geographic destination
Three Months Ended
March 31,
2025
2024
North America
$ 14,200
$ 10,850
United Kingdom
–
–
Rest of world
126,818
–
Total revenue
$ 141,018
$ 10,850
17
Contracts
Contract revenue is recognized over time using
the cost-to-cost measure of progress for fixed price contracts. The cost-to-cost measure of progress best depicts the continuous transfer
of control of goods or services to the customer. The contractual terms provide that the customer compensates the Company for services
rendered.
Contract costs include all direct materials, labor
and subcontracted costs, as well as indirect costs related to contract performance, such as indirect labor, supplies, tools, repairs and
the costs of capital equipment. The cost estimation and review process for recognizing revenue over time under the cost-to- cost method
is based on the professional knowledge and experience of the Company’s project managers, engineers and financial professionals.
Management reviews estimates of total contract transaction price and total project costs on an ongoing basis. Changes in job performance,
job conditions and management’s assessment of expected variable consideration are factors that influence estimates of the total
contract transaction price, total costs to complete those contracts and profit recognition. Changes in these factors could result in revisions
to revenue and costs of revenue in the period in which the revisions are determined on a prospective basis, which could materially affect
the Company’s consolidated results of operations for that period. Provisions for losses on uncompleted contracts are recorded in
the period in which such losses are determined.
Performance Obligations
A performance obligation is a contractual promise
to transfer a distinct good or service to the customer and is the unit of account under Accounting Standards Codification (“ASC”)
Topic 606. The transaction price of a contract is allocated to distinct performance obligations and recognized as revenue when or as the
performance obligations are satisfied. The Company’s contracts often require significant integrated services and, even when delivering
multiple distinct services, are generally accounted for as a single performance obligation. Contract amendments and change orders are
generally not distinct from the existing contract due to the significant integrated service provided in the context of the contract and
are accounted for as a modification of the existing contract and performance obligation. The majority of the Company’s performance
obligations are completed within one year.
When more than one contract is entered into with
a customer on or close to the same date, the Company evaluates whether those contracts should be combined and accounted for as a single
contract as well as whether those contracts should be accounted for as more than one performance obligation. This evaluation requires
significant judgment and is based on the facts and circumstances of the various contracts, which could change the amount of revenue and
profit recognition in a given period depending upon the outcome of the evaluation.
Contract Assets and Liabilities
The Company bill its customers based on contractual
terms, including, milestone billings based on the completion of certain phases of the work. Sometimes, billing occurs after revenue recognition,
resulting in unbilled revenue, which is accounted for as a contract asset. Sometimes the Company receives advances payments from our customers
before revenue is recognized, resulting in deferred revenue, which is accounted for as a contract liability.
Contract assets in the consolidated balance sheets
represents costs and estimated earnings in excess of billings, which arise when revenue has been recorded but the amount has not been
billed.
Contract assets and liabilities on March 31, 2025
are $ 0 upon the deconsolidation related to the Optilan liquidation.
18
Variable Consideration
Transaction pricing for the Company’s contracts
may include variable consideration, such as unapproved change orders, claims, incentives and liquidated damages. Management estimates
variable consideration for a performance obligation utilizing estimation methods that best predict the amount of consideration to which
the Company will be entitled. Variable consideration is included in the estimated transaction price to the extent it is probable that
a significant reversal of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration
is resolved. Management’s estimates of variable consideration and determination of whether to include estimated amounts in transaction
price are based on past practices with the customer, specific discussions, correspondence or preliminary negotiations with the customer,
legal evaluations and all other relevant information that is reasonably available. The effect of a change in variable consideration on
the transaction price of a performance obligation is typically recognized as an adjustment to revenue on a cumulative catch-up basis.
To the extent unapproved change orders, claims and liquidated damages reflected in transaction price are not resolved in the Company’s
favor, or to the extent incentives reflected in transaction price are not earned, there could be reductions in, or reversals of, previously
recognized revenue.
NOTE 6 – ACCOUNTS RECEIVABLE
Accounts receivable consisted of the following:
Schedule of accounts receivable
March 31,
2025
2024
Accounts receivable
$ 1,056,796
$ 915,044
Less: Allowance for doubtful accounts
( 5,458 )
–
Accounts receivable, net
$ 1,051,338
$ 915,044
NOTE 7 – PROPERTY AND EQUIPMENT, NET
Property and equipment, net consisted of the following:
Schedule of property and equipment
March 31,
2025
2024
Property and equipment
$ 1,092,242
$ 1,092,870
Leasehold improvements
38,460
46,934
Property and equipment at cost
1,130,702
1,139,804
Less - accumulated depreciation
( 468,650 )
( 415,810 )
Property and equipment, net
$ 662,052
$ 723,994
Depreciation expenses was $ 17,254
and $ 18,871 for the three months ended March 31, 2025
and 2024, respectively.
19
NOTE 8 - GOODWILL AND INTANGIBLE ASSETS
Goodwill
The following is a summary of activity of goodwill for the three
months ended March 31, 2025:
Schedule of goodwill activity
Goodwill
Balances at December 31, 2024
$ 23,965
Acquisition
–
Foreign exchange translation
–
Balances at March 31, 2025
$ 23,965
Patents - Intrusion Detection Intellectual
Property
The Company relies on patent laws and restrictions
on disclosure to protect its intellectual property rights. As of March 31, 2025 and 2024, the Company held three U.S. and foreign patents
on its intrusion detection technology, which expire in calendar years 2025 through 2034 (depending on the payment of maintenance fees).
The DPTI issued patents cover a System and Method
for Brillouin Analysis, a System and Method for Resolution Enhancement of a Distributed Sensor, and a Flexible Fiber Optic Deformation
System Sensor and Method. Maintenance of intellectual property rights and the protection thereof is important to our business. Any patents
that may be issued may not sufficiently protect the Company's intellectual property and third parties may challenge any issued patents.
Other parties may independently develop similar or competing technology or design around any patents that may be issued to the Company.
The Company cannot be certain that the steps it has taken will prevent the misappropriation of its intellectual property, particularly
in foreign countries where the laws may not protect proprietary rights as fully as in the United States. Further, the Company may be required
to enforce its intellectual property or other proprietary rights through litigation, which, regardless of success, could result in substantial
costs and diversion of management's attention. Additionally, there may be existing patents of which the Company is unaware that could
be pertinent to its business, and it is not possible to know whether there are patent applications pending that the Company's products
might infringe upon, since these applications are often not publicly available until a patent is issued or published.
For the three months ended March 31, 2025 and
2024, the Company had patent amortization costs on its intrusion detection technology totaling $ 12,727
and $ 14,212 ,
respectively. Patents costs are being amortized over the remaining life of each patent, which is from 7
to 16 years .
The DPTI issued patents cover a System and Method
for Brillouin Analysis, a System and Method for Resolution Enhancement of a Distributed Sensor, and a Flexible Fiber Optic Deformation
System Sensor and Method. Maintenance of intellectual property rights and the protection thereof is important to our business. Any patents
that may be issued may not sufficiently protect the Company's intellectual property and third parties may challenge any issued patents.
Other parties may independently develop similar or competing technology or design around any patents that may be issued to the Company.
The Company cannot be certain that the steps it has taken will prevent the misappropriation of its intellectual property, particularly
in foreign countries where the laws may not protect proprietary rights as fully as in the United States. Further, the Company may be required
to enforce its intellectual property or other proprietary rights through litigation, which, regardless of success, could result in substantial
costs and diversion of management's attention. Additionally, there may be existing patents of which the Company is unaware that could
be pertinent to its business, and it is not possible to know whether there are patent applications pending that the Company's products
might infringe upon, since these applications are often not publicly available until a patent is issued or published.
20
The following is a summary of the DPTI patents
as of March 31, 2025 and 2024:
Schedule of patents
March 31,
2025
2024
Patents
$ 904,269
$ 904,269
Less: accumulated amortization
( 714,391 )
( 650,606 )
Patents, net
$ 189,878
$ 253,663
Future expected amortization of patents is as follows:
Schedule of future expected amortization of patents
As of December 31,
2025
$ 51,028
2026
51,028
2027
51,028
Thereafter
36,794
Total patents
$ 189,878
NOTE 10 – ACCOUNTS PAYABLE AND ACCRUED
EXPENSES
Accounts payable and accrued expenses consists
of the following as of March 31, 2025 and March 31, 2024:
Schedule of accounts payable and accrued expenses
March 31,
2025
2024
Accounts payable
$ 14,566,593
$ 13,944,914
Accrued liabilities
2,765,373
2,155,928
Total accounts payable and accrued expenses
$ 17,331,966
$ 16,100,842
NOTE 11 – DEBT
Convertible Notes
The Company uses the Black-Scholes Model to calculate
the derivative value of its convertible debt. The valuation result generated by this pricing model is necessarily driven by the value
of the underlying common stock incorporated into the model. The values of the common stock used were based on the price at the date of
issue of the debt security as of March 31, 2025 and 2024. In 2024 management determined the expected volatility of 106.90%, a risk-free
rate of interest of 5.48%, and contractual lives of the debt of three months. In 2024 management determined the expected volatility of
140.30%, a risk-free rate of interest of 4.73%, and contractual lives of the debt of three months. Management made the determination
to use an expected life rather than contractual life for the calculations for the matured debt as of March 31, 2025 and 2024.
As of March 31, 2025 and, 2024, there was
$ 0 and $ 166,650
of convertible debt principal outstanding. During the three months ended March 31, 2025 and 2024, $ 0
and $ 0
of the debt discount was amortized.
The summary of convertible notes are:
Schedule of convertible notes
2025
2024
Principal Outstanding
$ –
$ 166,650
Less: unamortized debt discount
–
( 45,725 )
Convertible notes, net
$ –
$ 120,925
21
The table below details the Company's outstanding convertible notes
and related derivative liability:
Schedule of outstanding convertible notes and derivative liability
Face Amount
Derivative Liability
03/31/2025
03/31/2024
03/31/2025
03/31/2024
1800 Diagonal Lending
$ –
$ –
$ –
$ 108,958
Carebourn
–
–
–
–
Carebourn
–
–
–
–
More Capital
–
–
–
–
EMA
–
–
–
–
$ –
$ –
$ –
$ 108,958
During the three months ended March 31, 2025
and 2024, change in fair value of the derivative liability was $57,235 and $51,723, respectively. The following is a summary of the
derivative liability:
Schedule of derivative liability
Derivative Liability
Balances at December 31, 2024
$ ( 57,235 )
Loss on issuance of debt
–
Issuance of convertible note - 1800 Diagonal Lending
–
Change in fair value
–
EMA settlement
–
Balances at March 31, 2025
$ ( 57,235 )
Notes Payable
On August 27, 2024, the Company entered into a
promissory note for a principal of $ 67,200 , which was funded on August 30, 2024. The note bears interest at a rate of 12 % per annum and
matures after nine months.
On November 20, 2024, the Company entered into
a promissory note for a principal of $ 67,860 , which was funded on December 2, 2024. The note bears interest at a rate of 15 % per annum
and matures after nine months.
22
Loans Payable
The Company’s RI and WS subsidiaries have
various loans including Small Business Association (“SBA”) Economic Injury Disaster Loan (“EIDL’) loans, lines
of credit and other advances. The loans bear interest with varying rates up to 9.25% per annum. The following is a summary of the loans
payable at March 31, 2025 and December 31, 2024:
Schedule of loans
payable
March 31,
December 31,
2025
2024
RI - line of credit
$ 153,358
$ 153,358
RI - Short-term loans
46,544
46,544
WS - line of credit
218,616
218,616
WS - Short-term loans
151,970
151,970
OPT – Optilan Communications & Security Ltd
970
1,042
Loans payable, current
$ 571,458
$ 571,530
RI - SBA EIDL
$ 102,597
$ 102,597
RI - long-term loans
65,532
63,532
WS - SBA EIDL
26,307
26,307
WS - long-term loans
97,532
97,532
Loans payable, non-current
$ 291,967
$ 291,967
NOTE 12 – SECURED DEBENTURE
DPTI issued a convertible Debenture to the University
(see Note 1) in exchange for the Patents assigned to the Company, in the amount of Canadian $1,500,000, or US $1,491,923 on December 16,
2010, the date of the Debenture. On April 24, 2017 DPTI issued a replacement secured term Debenture in the same CAD 1,500,000 amount as
the original Debenture. The interest rate is the Bank of Canada Prime overnight rate plus 1% per annum. The Debenture had an initial required
payment of CAD 42,000 (US$33,385) due on April 24, 2018 for reimbursement to the University of its research and development costs, and
this has been paid. Interest-only maintenance payments are due annually starting after April 24, 2018. Payment of the principal begins
on the earlier of (a) three years following two consecutive quarters of positive earnings before interest, taxes, depreciation and amortization,
(b) six years from April 24, 2017, or (c) in the event DPTI fails to raise defined capital amounts or secure defined contract amounts
by April 24 in the years 2018, 2019, and 2020. The Company has raised funds in excess of the amount required for 2020, 2019 and 2018.
Beginning in 2023, The principal repayment amounts will be due quarterly over a six-year period in the amount of Canadian Dollars 62,500.
Based on the exchange rate between the Canadian Dollar and the U.S. Dollar on December 31, 2018, the quarterly principal repayment amounts
will be US$48,447. The Debenture is secured by the Patents assigned by the University to DPTI by an Assignment Agreement on December 16,
2010. DPTI has pledged the Patents, and granted a lien on them pursuant to an Escrow Agreement dated April 24, 2017, between DPTI and
the University.
The Debenture was initially recorded at the $1,491,923
equivalent US Dollar amount of Canadian 1,500,000 as of December 16, 2010, the date of the original Debenture. The liability is being
adjusted quarterly based on the current exchange value of the Canadian dollar to the US dollar at the end of each quarter. The adjustment
is recorded as unrealized gain or loss in the change of the value of the two currencies during the quarter. The Debenture also includes
a provision requiring DPTI to pay the University a 2% royalty on sales of any and all products or services which incorporate the Patents
for a period of five years from April 24, 2018. To date, no royalties have been paid.
23
For the three months ended March 31, 2025 and
2024, the Company recorded interest expense of $ 3,914
and $ 0 ,
respectively.
As of March 31, 2025 and 2024, the
outstanding balance of the debenture liability totaled $ 767,865 and $ 916,042 , respectively.
Future minimum required payments over the next
five years and thereafter are as follows:
Schedule of future minimum required payments
Period ending March 31,
2025
$ 181,543
2026
260,588
2027
260,588
2028
65,147
Total
$ 767,865
NOTE 13 – LEASES
The following was included in our balance sheet
as of March 31, 2025 and 2024:
Schedule of operating lease
March 31,
Operating leases
2025
2024
Assets
ROU operating lease assets
$ –
$ 485,178
Liabilities
Current portion of operating lease
–
80,400
Operating lease, net of current portion
–
484,545
Total operating lease liabilities
$ –
$ 564,945
The weighted average remaining lease term and
weighted average discount rate at March 31, 2025 and 2024 were as follows:
Schedule of weighted average remaining lease term and discount rate
March 31,
Operating leases
2025
2024
Weighted average remaining lease term (years)
0
7.25
Weighted average discount rate
0.00 %
6.00 %
Operating Leases
On January 15, 2025 SVEA Cameron Esperson filed
its Motion for Nonsuit without Prejudice. The dismissal was accepted by the court on January 16, 2025.
The following table reconciles future minimum
operating lease payments to the discounted lease liability as of March 31, 2025:
Schedule of future minimum operating lease payments
Three Months Ended March 31,
2025
$ 0
2026
0
2027 and later
0
Total lease payments
0
Less imputed interest
( 0 )
Total lease obligations
0
Less current lease obligations
( 0 )
Long-term lease obligations
$ 0
24
NOTE 14 – STOCKHOLDERS’ EQUITY (DEFICIT)
Preferred Stock
In accordance with the Company’s bylaws,
the Company has authorized a total of 2,000,000 shares of preferred stock, par value $ 0.01 per share, for all classes. As of March 31,
2025 and 2024 respectively, there were 88,335 and 88,335 total preferred shares issued and outstanding for all classes.
Common Stock
In accordance with the Company’s bylaws,
the Company has authorized a total of 20,000,000,000 shares of common stock, par value $ 0.0001 per share. As of March 31, 2025 and 2024,
there were 12,186,976,200 and 8,330,852,145 common shares issued, respectively.
2024 Transactions
On November 6, 2024 the Company entered into an
Amendment to the 2023 Equity Financing Agreement with GHS, to which GHS agreed to Purchase $ 30,000,000 in shares of our Common Stock over
the course of 12 months at 92 % of the current market price.
The below table of puts from 1/03/2025 through
3/27/2025 were made by the Company under the 2024 EFA during 2025:
Schedule of equity financing agreement
Date of Put
Number of Common Shares Issued
Total Proceeds, Net of Discounts
Effective Price per Share
Net Proceeds
1/3/2025
36,640,675
23,450
$ 0.000640
20,783
1/13/2025
51,215,454
32,778
$ 0.000640
29,458
1/22/2025
79,061,625
50,619
$ 0.000640
46,050
1/30/2025
139,008,500
55,603
$ 0.000400
50,686
2/7/2025
124,797,875
49,786
$ 0.000399
45,276
2/18/2025
131,445,657
42,063
$ 0.000320
38,093
2/27/2025
142,074,500
34,098
$ 0.000240
30,686
3/10/2025
132,699,709
31,848
$ 0.000240
28,594
3/18/2025
224,563,917
53,895
$ 0.000240
40,098
3/27/2025
203,844,344
65,230
$ 0.000320
59,639
The RRA provides that we shall (i) use our best
efforts to file with the SEC a Registration Statement within 45 days of the date of the GHS Registration Rights Agreement; and (ii) have
the Registration Statement declared effective by the SEC within 30 days after the date the GHS Registration Statement is filed with the
SEC, but in no event more than 90 days after the GHS Registration Statement is filed.
Stock Options
As of March 31, 2025 and 2024, the Company had no outstanding stock
options.
25
NOTE 15 – INCOME TAXES
The provision for income taxes for the three
months ended March 31, 2025 and 2024 differs from the amount which would be expected as a result of applying the statutory tax rates
to the losses before income taxes due primarily to the valuation allowance to fully reserve net deferred tax assets.
The following table summarizes the significant
differences between statutory rates for the three months ended March 31, 2025 and 2024:
Schedule of statutory rates
2025
2024
Statutory tax rate:
U.S.
21.00 %
21.00 %
State taxes
1.36 %
1.36 %
Foreign rate differential
1.26 %
1.26 %
Goodwill impairment
- 7.33 %
- 7.33 %
NOLs carryforward adjustment
3.61 %
3.61 %
Other
- 0.22 %
- 0.22 %
Change in valuation allowance:
- 19.67 %
- 19.67 %
– %
– %
The Company’s deferred tax assets and liabilities
as of March 31, 2025 and 2024 are as follows:
Schedule of deferred
tax assets and liabilities
2025
2024
Deferred Tax (Liabilities):
Net operating losses
$ 8,964,470
$ 8,964,470
Intangible assets
( 736,905 )
( 736,905 )
Right of use asset
84,170
84,170
Stock based compensation
424,681
424,681
Property and equipment
497,037
497,681
Other
11,077
11,077
Less: Valuation allowance
( 9,244,530 )
( 9,244,530 )
Deferred tax assets (liabilities)
$ –
$ –
The Company has approximately $ 26,485,942 of federal
and state net operating loss carryforwards as of March 31, 2025. Of the $26.4 million of NOL's, $ 4.8 million will begin to expire in 2023
while $ 15.9 million will not expire but will be limited to 80% utilization. The company also has net operating losses in the UK of $ 22,085,338
and $ 636,852 of net operating loss carryforwards in Canada which will begin to expire in 2038.
The Company records a tax valuation
allowance when it is more likely than not that it will not be able to recover the value of its deferred tax assets. For the three
months ended March 31, 2025 and 2024, the Company calculated its estimated annualized effective tax rate at 0 %
and 0 %,
respectively, for both the United States, Canada and the UK. The Company had no
income tax expense on its losses for the three months ended March 31, 2025 and 2024, respectively.
The Company recognizes the financial statement
benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following
an audit. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the financial statements is the largest
benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the relevant tax authority. The Company
recognizes interest accrued on uncertain tax positions as well as interest received from favorable tax settlements within interest expense.
The Company recognizes penalties accrued on unrecognized tax benefits within selling, general and administrative expenses. As of March
31, 2025 and 2024, the Company had no uncertain tax positions.
26
The Company does not anticipate any significant
changes to the total amounts of unrecognized tax benefits in the next twelve months. The Company files income tax returns in New Brunswick,
Canada, and the U.S. federal, New York, and Delaware and the UK jurisdictions. Tax years 2012 to current remain open to examination by
Canadian authorities; the tax year 2020 remains open to examination by U.S. authorities.
NOTE 16 – COMMITMENTS AND CONTINGENCIES
Legal Matters
Carebourn
Capital, L.P. v. DarkPulse, Inc .
On
or about January 29, 2021, Carebourn Capital, L.P. (“ Carebourn ”) commenced an action against the Company in Minnesota
State Court. Carebourn alleged that the Company was in breach of certain securities purchase agreements and convertible promissory notes
sold to Carebourn on or about July 17, 2018 and July 24, 2018.
On
or about August 31, 2021, the Company answered Carebourn’s complaint and interposed affirmative defenses, including that Carebourn
was an unregistered “dealer,” as such term is defined in the Securities Exchange Act of 1934 (“ Exchange Act ”)
and, therefore, all contracts between the parties arising from or related to the securities purchase agreements and convertible promissory
notes sold to Carebourn on or about July 17, 2018 and July 24, 2018 were void pursuant to the Exchange Act. The Company also asserted
counterclaims against Carebourn under the Minnesota Securities Act.
On
or about April 21, 2023, the State Court ruled in the Company’s favor on its motion for partial summary judgment on its Exchange
Act defense, holding that (i) Carebourn is a “dealer” under the Exchange Act in violation of the mandatory registration
requirement imposed thereby, and (ii) all contracts between the parties are void.
On
or about November 17, 2023, the State Court ruled in the Company’s favor on its motion for summary judgment on its Minnesota Securities
Act counterclaims against Carebourn and awarded damages for Carebourn’s violation of Minn. Stat. § 80A.76(d) in the amount
of $124,012.91, attorney’s fees in the amount of $239,923.33 and costs in the amount of $23,757.24 (or a total award in the amount
of $387,693.48).
As
of the date hereof, the final judgment remains unsatisfied by Carebourn. DarkPulse intends to continue to exercise all legal rights and
remedies available to it to collect the amounts awarded should Carebourn fail to voluntarily pay the same.
More
Capital, LLC v. DarkPulse, Inc. et al
On
or about June 29, 2021, More Capital, LLC (“ More ”) commenced an action against the Company in Minnesota State Court.
More alleged that the Company was in breach of a certain securities purchase agreement and convertible promissory note sold to More on
or about August 20, 2018.
On
or about September 3, 2021, the Company answered More’s complaint and interposed affirmative defenses, including that More was
an unregistered “dealer,” as such term is defined in the Exchange Act and, therefore, all contracts between the parties arising
from or related to the securities purchase agreement and convertible promissory note sold to More on or about August 20, 2018 were void
pursuant to the Exchange Act. The Company also asserted counterclaims against More under the Minnesota Securities Act.
On
or about December 11, 2023, the Minnesota State Court ruled in the Company’s favor on its motion for summary judgment on its (a) Exchange
Act defense, holding that (1) More is a “dealer” under the Exchange Act in violation of the mandatory registration requirement
imposed thereby, and (ii) all contracts between the parties are void, and (b) Minnesota Securities Act counterclaims against
More and awarded damages for More’s violation of Minn. Stat. § 80A.76(d) in the amount of $300,809.39, attorney’s
fees in the amount of $110,029.00 and costs in the amount of $210.25 (or a total award in the amount of $412,048.64).
As
of the date hereof, the final judgment remains unsatisfied by More. DarkPulse intends to continue to exercise all legal rights and remedies
available to it to collect the amounts awarded should More fail to voluntarily pay the same.
27
Carebourn
Capital et al v. Standard Registrar and Transfer et al
On
or about May 20, 2022, Carebourn and More (More, together with Carebourn, the “ Noteholders ”) commenced an action against
the Company, certain members of the Company’s executive team and board of directors and Standard Registrar and Transfer Company,
Inc., the Company’s transfer agent, in the United States District Court for the District of Utah. The Noteholders’ complaint
alleged various causes of action arising from certain securities purchase agreements and convertible promissory notes the Company sold
to the Noteholders.
On
or about November 1, 2023, the Noteholders moved to dismiss the action.
On
or about November 2, 2023, the Company moved for sanctions against the Noteholders and their counsel of record.
On
or about December 4, 2023, the Court entered an order granting dismissal of the Noteholders’ claims with prejudice. The Court acknowledged
that notwithstanding its dismissal of the Noteholders’ claims, the Court continues to retain jurisdiction over the Noteholders
because of DarkPulse’s pending motion for sanctions against the Noteholders and their attorneys.
On
September 10, 2024, the Court entered an order granting in part the Company’s motion for sanctions against the Noteholders and
their counsel of record.
As
of the date hereof, the Court has not yet rendered its decision on the amount sanctions that will be imposed against the Noteholders
and their counsel of record and awarded to the Company.
DarkPulse,
Inc. v. FirstFire Global Opportunities Fund, LLC, and Eli Fireman
On
or about December 31, 2021, the Company commenced an action against FirstFire Global Opportunities Fund, LLC (“ FirstFire ”)
and its control person, Eli Fireman (“ Fireman ,” and together with FirstFire, the “ FirstFire Defendants ”),
in the United States District Court for the Southern District of New York.
On
or about May 5, 2022, the Company amended its complaint against the FirstFire Defendants. The amended complaint alleges that the FirstFire
Defendants were liable to the Company for rescission of certain convertible promissory notes and transitions effected thereunder and
damages pursuant to the Racketeer Influenced and Corrupt Organizations Act (“ RICO ”).
On
or about January 17, 2023, the Court granted the FirstFire Defendants’ motion to dismiss the Company’s operative pleading.
On the same day, the Company appealed the Court’s decision to the United States Court of Appeals for the Second Circuit (“ Second
Circuit ”).
On
March 28, 2024, the Second Circuit issued its decision and found that the District Court (a) properly found that the Delaware forum-selection
clause was enforceable but, thereafter, (b) improperly made a ruling on the merits of the Company’s claims for relief. As
a result, the Second Circuit affirmed the District Court’s decision in part, vacated in part and remanded the case back to the
District Court for transferring to the United States District Court for the District of Delaware.
On
September 9, 2024, the FirstFire Defendants filed their opening memorandum of law in support of their motion to dismiss. Shortly thereafter,
the Company opposed the FirstFire Defendants’ motion and the FirstFire Defendants filed their reply in further support.
As
of the date hereof, the Court has not scheduled oral arguments on the FirstFire Defendants’ motion to dismiss or rendered its decision
thereon. The Company remains committed to actively litigating its claims for relief against the FirstFire Defendants.
28
DarkPulse,
Inc., et al v. Crown Bridge Partners, LLC, et al
On
or about September 23, 2022, the Company, Social Life Network, Inc. and Redhawk Holdings Corp. commenced an action against Crown Bridge
Partners, LLC (“ Crown Bridge ”) and its control persons, Soheil Ahdoot and Sepas Ahdoot (collectively, the “ Crown
Bridge Defendants ”) in the United States District Court for the Southern District of New York. The complaint alleges that the
Crown Bridge Defendants are liable to each of the plaintiffs for damages pursuant to RICO.
On
or about September 29, 2023, the Court granted the Crown Bridge Defendants’ motion to dismiss the plaintiffs’ complaint.
On
October 23, 2023, the plaintiffs appealed the Court’s decision to the United States Court of Appeals for the Second Circuit (“ Second
Circuit ”).
On
August 19, 2024, the Second Circuit issued its decision and found that the District Court erred when granting the Crown Bridge Defendants’
motion to dismiss. As a result, the Second Circuit vacated the District Court’s decision and remanded the case back to the District
Court for further proceedings consistent with its decision.
On
September 30, 2024, the District Court entered a scheduling order, setting forth deadlines for discovery and dispositive motion practice.
The
Company is actively litigating its claims for relief against the Crown Bridge Defendants.
GS
Capital Partners, LLC v. DarkPulse, Inc.
On
June 2, 2023, GS Capital Partners, LLC (“ GS Capital ”) commenced an action in the Supreme Court for New York County
against the Company through the filing of motion for summary judgment in lieu of a complaint. The motion claims that the Company is in
breach of a convertible promissory note, dated July 14, 2021, and accompanying securities purchase agreement, dated the same.
The
motion claims that GS Capital is entitled to an award of $2,407,671, plus prejudgment interest and attorney’s fees, costs and disbursements.
On
July 27, 2023, the Company moved to set aside the default judgment entered in favor of GS Capital and against the Company on July 25,
2023. GS Capital’s opposition thereto is due on or before August 31, 2023. Thereafter, DarkPulse’s reply is due on or before
September 6, 2023. Oral arguments are currently not scheduled on the Company’s motion.
On
or about September 27, 2023, the Company and GS Capital confidentially settled the dispute. On or about October 3, 2023, the parties
filed a stipulation with the court to vacate the judgment entered against the Company and in favor of GS Capital, vacate the motion filed
by the Company, and discontinue the action.
On
or about October 9, 2023, the court vacated the judgment and the action was dismissed.
The
Company defaulted upon the settlement and, on July 24, 2024, the Company and GS Capital entered into a Settlement Agreement pursuant
to which the Company entered into a confession of judgment in favor of GS Capital in the amount of $2,673,423.19 (the “ Balance ”).
Upon approval of the court on August 19, 2024, the Company will issue to GS Capital free-trading and unrestricted shares of Common Stock
pursuant to drawdown requests in the amounts determined by GS Capital, subject to a 4.99% beneficial ownership limitation. The shares
will be issued a price per share equal to the average of the three lowest VWAPs for the five prior trading days. GS Capital will be allowed
to sell, the greater of (1) in one week, no more than 1% of the total outstanding shares of the Company on a non-cumulative basis at
the “ask” price, and (2) 15% of the daily trading volume of the Common Stock on any single trading day. Each drawdown will
reduce the Balance. The Company is required to reserve 2,500,000,000 shares of Common Stock.
29
TJM
West, Inc v Thomas J McCarthy Family Limited Partnership
On
or about July 25, 2023, TJM West filed an action in Maricopa court against its landlord for illegal lockout from the company’s
facilities.
On
or about August 18, 2023, TJM West’s motion for Temporary Restraining Order was granted.
September
27, 2023, TJM West counsel motion to withdraw was accepted.
On
or about October 6, 2923, TJM West hired new counsel to assist with a short deadline to file answers to landlords motion.
On
or about November 6, 2023, TJM West and its counsel mutually agreed to a withdrawal.
On
or about November 6, 2023, TJM West engaged new counsel.
On
or about May 8, 2024, TJM West dropped its motion for Temporary Restraining Order.
On
or about May 24, 2024, TJM West counsel filed motion to continue discovery.
On
or about May 24, 2024, TJM West’s counsel left the firm handling the litigation it was determined in the best interest of the company
to terminate its relationship with the law firm. As of the date hereof, the Company is interviewing new counsel and evaluating its claims
against landlord to determine if it’s financially responsible to incur additional fees related to exercising TJM’s rights
against the landlord for terminating the lease.
On
or about June 28, 2024, the Company discussed with possible new counsel the feasibility of recovering its damages utilizing the courts.
At that time, it appeared the cost of recovery would exceed the recoverable amount should the Company be successful in its litigation.
TJM West is awaiting updates from the court in Maricopa County as to the status of the case.
The
facilities in question had served as TJM West’s manufacturing facility and is located at 2640 W Medtronic Way Tempe, AZ 85281.
Currently, we do not have access to the facility nor have we signed a new lease signed with the landlord.
In
addition to the foregoing Legal Proceedings, we are also actively investigating potential legal claims, including but not limited to
stock fraud, market manipulation, and/or defamation, against certain Twitter accounts, websites, and social media channels. The investigation
is ongoing and should potential claims be identified, we will evaluate commencing formal litigation proceedings.
From
time to time, we may become involved in litigation relating to claims arising out of our operations in the normal course of business.
We are not currently involved in any pending legal proceeding or litigation and, to the best of our knowledge, no governmental authority
is contemplating any proceeding to which we are a party or to which any of our properties is subject, which would reasonably be likely
to have a material adverse effect on our business, financial condition and operating results.
30
NOTE 17 – RELATED PARTY TRANSACTIONS
The Company follows subtopic 850-10 of the FASB
Accounting Standards Codification for the identification of related parties and disclosure of related party transactions. Pursuant to
Section 850-10-20 the related parties include a) affiliates of the Company; b) Entities for which investments in their equity securities
would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825-10-15, to be accounted
for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and profit- sharing trusts
that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other
parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of
the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g)
Other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership
interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting
parties might be prevented from fully pursuing its own separate interests. The financial statements shall include disclosures of material
related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course
of business. However, disclosure of transactions that are eliminated in the preparation of consolidated or combined financial statements
is not required in those statements. The disclosures shall include: a) the nature of the relationship(s) involved; b) a description of
the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income
statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial
statements; c) the dollar amounts of transactions for each of the periods for which income statements are presented and the effects of
any change in the method of establishing the terms from that used in the preceding period; and d) amounts due from or to related parties
as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement.
On January 20, 2025 Optilan India Pvt, Ltd.entered
into a director’s loan agreement to lend funds whenever the company requires money for working capital over the period of two years.
The loan is unsecured, and non-interest bearing with repayment being mutually agreed upon between Lender and Borrower.
Remote Intelligence and Wildlife Specialists
Loan Payables
RI has a loan payable with the former
majority shareholder, who is a shareholder in the Company after the acquisition of 60% of RI’s membership interests. The loan
is unsecured, non-interest bearing and due on demand. As of both three months ended March 2025 and 2024, the outstanding balance was
$ 226,247 .
WS has a loan payable with the former
majority shareholder, who is a shareholder in the Company after the acquisition of 60% of WS’s membership interests. The loan
is unsecured, non-interest bearing and due on demand. As of both three months ended March 2025 and 2024, the outstanding balance was
$ 135,500 .
NOTE 18 – SUBSEQUENT EVENTS
On April 4, 2025, the Company issued 130,615,137
shares of common stock for a total consideration of $41,796.85
On April 14, 2025, the Company issued 179,014,375
shares of common stock for a total consideration of $42,963.45
On April 23, 2025, the Company issued 181,334,313
shares of common stock for a total consideration of $58,026.98
On May 1, 2025, the Company issued 188,280386
shares of common stock for a total consideration of $46,844,16
On May 9, 2025, the Company issued 225,384,480
shares of common stock for a total consideration of $43,273.82
31
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.